A modern approach to the combination treatment of allergic rhinitis
https://doi.org/10.21518/2079-701X-2018-20-92-95
Abstract
Allergic rhinitis is a common disease that significantly worsens the patient’s quality of life. In some cases, the disease can be life threatening. Severe attacks of bronchial obstruction may occur in patients with allergic rhinitis. The widespread prevalence of allergic rhinitis in adults and children, consistent increase in disease incidence constitutes a great medical and social issue. Treatment for allergic rhinitis should be aimed at reaching increased remission duration, preventing the exacerbation of the disease and educating patients to maintain control over the symptoms of the disease. A challenge that otolaryngologists and allergists face is to restore nasal breathing in patients with allergic rhinitis. The updated approach to the challenge is to suggest treatment that takes into account the pathophysiological mechanisms that occur not only in the mucous membrane of the nasal cavity, but throughout the body, in particular, in the intestine.
About the Authors
S. A. KarpischenkoRussian Federation
G. V. Lavrenova
Russian Federation
E. I. Muratova
Russian Federation
References
1. Bulkina OZ, Markova TP. Clinical and immunological characteristics of patients with perennial allergic rhinitis and chronic oral and nasopharyngeal foci of infection. Immunologia, 2007, 1: 46-49.
2. Arkhipov VV. Clinical pharmacology of inhaled glucocorticosteroids. Prakticheskaya Pulmonologiya, 2014, 1: 57-64.
3. Garashchenko TI. Modern therapy of allergic rhinitis in children. RMJ. Pulmonologia. Allergologia, 2002, 5: 273-277.
4. Tkach SM, Puchkov KS, Sizenko AK. Intestinal microbiota and functional bowel disease. Suchasna Gastroenterologіya 2014, 1 (75): 118-127.
5. Bagisheva NV, Ivashchuk EV, Dubrovskaya II. Some aspects of the effect of inhaled glucocorticosteroids on the mucosa of the oropharynx. Folia Otorhinolaryngologiae et Pathologiae Respiratoriae, 2014, 3 (20): 6-8.
6. Voznesensky NA. Revisiting the safety of inhaled and intranasal glucocorticosteroids. Prakticheskaya Pulmonologia, 2005, 2: 50-54.
7. Nesterova AA, Nesterova KI. Topical antihistamine therapy of allergic rhinitis Folia otorhinolaryngologiae et pathologiae respiratoriae, 2015, 21 (2): 109-111.
8. Mokronosova MA, Sergeev AV, Tarasova GD, et al. Characte ristics of the microflora of the mucosa of the upper respiratory tract in allergic rhinitis. Rossiyskaya Otorinolaringologiya, 2003, 2: 134-138.
9. Nesterov IA. Features of surgical anatomy of the middle nasal passage structures from the standpoint of functional endoscopic interventions. Patologiya Verkhnikh Dykhatelnykh Putey I Golosa: Sbornik Statey Nauchno-Prakticheskoy Konferentsii, Posvyaschennoy 30-Letiyu Omskogo Gorodskogo Foniatricheskogo Tsentra. Under the editorship of Krotov YuA, Nesterova KI, Drachuk AI. Omsk, 2006: 76-79.
10. Gushchin IS, Kurbacheva OS. Allergy and allergen-specific immunotherapy. M.: Farmarus Print Media, 2010. 165 p.
11. https://www.rlsnet.ru/tn_index_id_3385.htm.
Review
For citations:
Karpischenko SA, Lavrenova GV, Muratova EI. A modern approach to the combination treatment of allergic rhinitis. Meditsinskiy sovet = Medical Council. 2018;(20):92-95. (In Russ.) https://doi.org/10.21518/2079-701X-2018-20-92-95